CASTLE BIOSCIENCES, INC. Gain (Loss) on Extinguishment of Debt
CASTLE BIOSCIENCES, INC. (CSTL) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2022-02-28
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2020-12-31 was -$1.40M.
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-12-31 was $0.00.
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-09-30 was $5.20M.
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2020 was -$1.40M, a 126.80% decline from fiscal 2019.
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2019 was $5.21M.
- CASTLE BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2018 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |||||
| 2020-12-31 | -$1.40M 10-K · filed 2021-03-11 | -$1.40M derived: sum of 2 quarters · filed 2021-03-11 | -$1.40M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $5.20M derived: sum of 2 quarters · filed 2021-03-11 | $5.21M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $5.20M 10-K · filed 2021-03-11 | $5.21M 10-Q · filed 2019-11-12 | $5.21M 10-Q · filed 2020-11-09 | $5.21M 10-Q · filed 2019-11-12 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |